Private company

Cold Spring Harbor Laboratory

Logo: The logo is from the following website: http://www.cshl.edu/ CSH website http://www.cshl.edu/Contact-Us/logos, Non-free logo, via Wikipedia4

Private, non-profit research institution in US

Cold Spring Harbor Laboratory (CSHL) is a private, non-profit institution with research programs focusing on cancer, neuroscience, botany, genomics, and quantitative biology. It is located in Laurel Hollow, New York, in Nassau County, on Long Island. It is one of 68 institutions supported by the Cancer Centers Program of the U.S. National Cancer Institute (NCI) and has been an NCI-designated Cancer Center since 1987.2 Its revenue was $233 million in 2024.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 20, 2026.

Overview

1890Founded1
  • Industryresearch1
  • HeadquartersCold Spring Harbor, United States1
  • Websitewww.cshl.edu
  • Legal form501(c)(3) organization1
  • LEI5493000JV8XXJ7ZOV8623
  • StatusInactive3
  • LEI statusRetired3
  • Registered addressC/O COLD SPRING HARBOR LABORATORY, 11724 Cold Spring Harbor, United States3
  • Registered withCorporation and Business Entity Database (Division of Corporations, State Records and UCC, Department of State), 189673

Cold Spring Harbor Laboratory (CSHL) is a private, non-profit institution with research programs focusing on cancer, neuroscience, botany, genomics, and quantitative biology. It is located in Laurel Hollow, New York, in Nassau County, on Long Island.2

Corporate structure

Cold Spring Harbor Laboratory sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.

What it owns

What Cold Spring Harbor Laboratory reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Stakes and holdings (Wikidata)

  • bioRxiv

Things Wikidata records the company as owning, with the share when stated.1

The story

The institution took root as The Biological Laboratory in 1890, a summer program for the education of college and high school teachers studying zoology, botany, comparative anatomy and nature. The program began as an initiative of Eugene G. Blackford and Franklin Hooper, director of the Brooklyn Institute of Arts and Sciences, the founding institution of The Brooklyn Museum. In 1904, the Carnegie Institution of Washington established the Station for Experimental Evolution at Cold Spring Harbor on an adjacent parcel. In 1921, the station was reorganized as the Carnegie Institution Department of Genetics.

Between 1910 and 1939, the laboratory was the base of the Eugenics Record Office of biologist Charles B. Davenport and his assistant Harry H. Laughlin, two prominent American eugenicists of the period. Davenport was director of the Carnegie Station from its inception until his retirement in 1934. In 1935 the Carnegie Institution sent a team to review the ERO's work, and as a result the ERO was ordered to stop all work. In 1939 the Institution withdrew funding for the ERO entirely, leading to its closure. The ERO's reports, articles, charts, and pedigrees were considered scientific facts in their day, but have since been discredited. Its closure came 15 years after its findings were incorporated into the National Origins Act (Immigration Act of 1924), which severely reduced the number of immigrants to America from southern and eastern Europe who, Harry Laughlin testified, were racially inferior to the Nordic immigrants from England and Germany. Charles Davenport was also the founder and the first director of the International Federation of Eugenics Organizations in 1925. Today, Cold Spring Harbor Laboratory maintains the full historical records, communications and artifacts of the ERO for historical, teaching and research purposes. The documents are housed in a campus archive and can be accessed online and in a series of multimedia websites.

Carnegie Institution scientists at Cold Spring Harbor made many contributions to genetics and medicine. In 1908 George H. Shull discovered hybrid corn and the genetic principle behind it called heterosis, or "hybrid vigor." This would become the foundation of modern agricultural genetics. In 1916, Clarence C. Little was among the first scientists to demonstrate a genetic component of cancer. E. Carleton MacDowell in 1928 discovered a strain of mouse called C58 that developed spontaneous leukemia – an early mouse model of cancer. In 1933, Oscar Riddle isolated prolactin, the milk secretion hormone and Wilbur Swingle participated in the discovery of adrenocortical hormone, used to treat Addison's disease.

Milislav Demerec was named director of the Laboratory in 1941. Demerec shifted the Laboratory's research focus to the genetics of microbes, thus setting investigators on a course to study the biochemical function of the gene. During World War Two, Demerec directed efforts at Cold Spring Harbor that resulted in major increases in penicillin production.

Beginning in 1941, and annually from 1945, three of the seminal figures of molecular genetics convened summer meetings at Cold Spring Harbor of what they called the Phage Group. Salvador Luria, of Indiana University; Max Delbrück, then of Vanderbilt University; and Alfred Hershey, then of Washington University in St. Louis, sought to discover the nature of genes through study of viruses called bacteriophages that infect bacteria.

In 1945, Delbrück's famous Phage Course was taught for the first time, inspiring, among others, a young James D. Watson; it was repeated for many years after. CSH Symposia important in the cross-fertilization of ideas among molecular biology's pioneers were held in 1951, 1953, 1956, 1961, 1963, and 1966.

At the CSH Symposium in summer 1953, Watson made the first public presentation of DNA's double-helix structure.

From Wikipedia’s article on Cold Spring Harbor Laboratory, shared under CC BY-SA 4.0.5

Leadership

Who has led Cold Spring Harbor Laboratory, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (1)

Products and brands

Research staff in CSHL's 52 laboratories numbers over 600, including postdoctoral researchers; an additional 125 graduate students and 500 administrative and support personnel bring the total number of employees to over 1,200.

Cell biology and genomics

RNA interference (RNAi) and small-RNA biology; DNA replication; RNA splicing; signal transduction; genome structure; non-coding RNAs; deep sequencing; single-cell sequencing and analytics; stem cell self-renewal and differentiation; chromatin dynamics; structural biology; advanced proteomics; mass spectrometry; advanced microscopy.

Cancer research

Read the full text

Principal cancer types under study: breast, prostate, blood (leukemia, lymphoma); myelodysplastic syndrome; melanoma; liver; ovarian and cervical; lung; brain; pancreas. Research foci: drug resistance; cancer genomics; tumor microenvironment; cancer metabolism; growth control in mammalian cells; transcriptional and post-transcriptional gene regulation.

Neuroscience

Stanley Institute for Cognitive Genomics employs deep sequencing and other tools to study genetics underlying schizophrenia, bipolar disorder, and major depression. Swartz Center for the Neural Mechanisms of Cognition studies cognition in the normal brain as a baseline for understanding dysfunction in psychiatric and neurodegenerative disorders. Other research foci: autism genetics; mapping of the mammalian brain; neural correlates of decision making.

Plant biology

Plant genome sequencing; epigenetics and stem cell fate; stem cell signalling; plant-environment interactions; using genetic insights to increase yield of staple crops, e.g. maize, rice, wheat; increase fruit yield in flowering plants, e.g. tomato. Other initiatives: genetics of aquatic plants for biofuel development; lead role in building National Science Foundation's iPlant Collaborative cyberinfrastructure. Much of this work takes place on 12 acres of farmland at the nearby CSHL Uplands Farm, where expert staff raise crops and Arabidopsis plants for studies. Seven CSHL faculty members conduct research primarily in plant biology - Drs. David Jackson, Zachary Lippman, Robert Martienssen, Richard McCombie, Ullas Pedmale, Doreen Ware, and Thomas Gingeras.

Simons Center for Quantitative Biology

Genome assembly and validation; mathematical modeling and algorithm development; population genetics; applied statistical and machine learning; biomedical text-mining; computational genomics; cloud computing and Big Data.

COVID-19

Scientists at Cold Spring Harbor Laboratory (CSHL), Utah Health University, PEEL Therapeutics, and Weill Cornell Medicine worked to examine the possible function of NETs in COVID-19, gather blood samples from 33 hospitalized individuals, as well as autopsy tissue. Neutrophil Extracellular Traps (NETs) are a form of protection which is utilized by the immune system against certain pathogens.

From Wikipedia’s article on Cold Spring Harbor Laboratory, shared under CC BY-SA 4.0.5

Subsidiaries and ownership

Subsidiaries

Also owns

  • bioRxiv

From Wikidata.1

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

Cold Spring Harbor Laboratory revenue by year1$232.7M in 2024+74% since 2015
0$100.0M$200.0M$300.0M$400.0M2015: $133.8M$133.8M20152016: $170.2M$170.2M2016+27%2017: $214.1M$214.1M2017+26%2018: $212.5M$212.5M2018−1%2019: $307.6M$307.6M2019+45%2020: $184.4M$184.4M2020−40%2021: $202.3M$202.3M2021+10%2022: $207.4M$207.4M2022+3%2023: $258.0M$258.0M2023+24%2024: $232.7M$232.7M2024−10%
  • 2024$232.7M1
  • 2023$258.0M1
  • 2022$207.4M1
  • 2021$202.3M1
  • 2020$184.4M1
  • 2019$307.6M1

Timeline

  1. 1890Founded Founded1